Medicines + Health
Partnerships and collaborations are central to our goal of bringing our pipeline of small molecule therapeutics to treat age-related and chronic diseases.
Partnering
We are seeking a pharma partner to support us in bringing VNA-318, our innovative, differentiated, well-tolerated once-daily oral drug, to patients with Alzheimer’s and other CNS disorders.
Contact Us
To discuss a potential collaboration, email info@vandria.com.
